TURBO-BULL-CERTIFICATE - IPSEN | Real-time Euronext Paris 01:48:36 20/05/2024 pm IST | ||
| 1.075 EUR | +1.90% |
|
| Current month | +43.54% | ||
| 1 month | +189.04% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 20/24/20 | 1.075 | +1.90% |
| 17/24/17 | 1.055 | -3.65% |
| 16/24/16 | 1.095 | +1.86% |
| 15/24/15 | 1.075 | -2.71% |
| 14/24/14 | 1.105 | +13.33% |
Real-time Euronext Paris
Last update May 20, 2024 at 01:48 pm IST
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 5S66S | |
| ISIN | DE000SW75V98 |
| Date issued | 25/03/2024 |
| Strike | 100 € |
| Maturity | 21/06/2024 (33 Days) |
| Parity | 20 : 1 |
| Emission price | 0.5 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.135 € |
|---|---|
| Lowest since issue | 0.305 € |
| Spread | 0.01 € |
| Spread % | 0.92% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.8
EUR
Average target price
126.3
EUR
Spread / Average Target
+4.58%
- Stock Market
- Certificates
- 5S66S Certificat
